Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07127575 · ClinicalTrials.gov registry record · NA
Scalable Intervention for Stress Management
A NA study of Stress and Diaphragmatic Breathing, sponsored by Livotion.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07127575: Recruiting NA study of Stress and Diaphragmatic Breathing, sponsored by Livotion.
NCT07127575 is a NA study of Stress and Diaphragmatic Breathing that is actively recruiting participants, run by Livotion. The registered enrollment target is 60 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07127575, a NA study of Stress and Diaphragmatic Breathing, is actively recruiting participants, sponsored by Livotion.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to measure the acceptance of a resistance breathing intervention and to assess whether it produces physiological and subjective effects in a laboratory setting.
Primary Outcome
The AIM measure is designed to assess the acceptability of a intervention, and has been adapted in relation to the AIRpen. Participants rate statements related to their usage and experience of the AIRpen and AIRpen website, with ratings ranging from "Completely Disagree" (1), to "Completely Agree" (5). Higher scores indicate higher acceptability of the intervention.
Conditions Studied
Interventions
- DEVICE Resistance Breathing Device
- DEVICE Electronic Resistance Breathing Device
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What NCT07127575 shows while recruiting
NCT07127575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Resistance Breathing Device is the first listed.
NCT07127575 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07127575 about?
NCT07127575 is a clinical study titled "Scalable Intervention for Stress Management". The purpose of this research is to measure the acceptance of a resistance breathing intervention and to assess whether it produces physiological and subjective effects in a laboratory setting.
What is the current status of trial NCT07127575?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-01. Estimated completion is 2025-09-30.
What conditions does trial NCT07127575 study?
This clinical trial studies the following conditions: Stress, Diaphragmatic Breathing.
What interventions are being tested in trial NCT07127575?
The interventions under investigation include: Resistance Breathing Device (DEVICE), Electronic Resistance Breathing Device (DEVICE).
Who is sponsoring clinical trial NCT07127575?
This trial is sponsored by Livotion, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07127575 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07127575's enrollment target sits among peer trials
60 91st of 152 higher than 57 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI